Protein Engineering Market Worth About USD 3.09 billion By 2025
What is a Protein engineering?
Protein engineering is a method to design novel proteins or
enzymes with the intention to have functional properties. Protein engineering
is primarily based on the use of recombinant DNA technology to alter the amino
acid sequences in terms of affinity, solubility, activity, resistance, etc.
The
factors that propel the growth of the Protein Engineering industry include
increasing occurrence of lifestyle associated diseases, increasing
consciousness regarding healthcare, increasing healthcare expenditure, and
growing adoption of protein-based drugs. On the other hand, there are factors
that may hamper the growth of the market including lack of skilled expertise,
maintenance, and high price of tools as well as instruments utilized during
protein engineering. Protein Engineering Market is anticipated to grow at a
significant CAGR of 15.9% in the upcoming period as the scope, product types,
and its applications are increasing across the globe.
The
market may be explored by product type, technology, protein type, end users,
and geography. The market may be explored by product type as services and
software, instruments, and reagents. The “Instruments” segment dominated the
market in 2016 and is anticipated to maintain its dominance in the forecast
period.
Request Sample Copy of This Market Research @
https://www.millioninsights.com/industry-reports/protein-engineering-market/request-sample
The
key technologies that could be explored in the Protein Engineering industry
include Irrational Protein Design, and Rational Protein Design. The “Rational
Protein Design” segment dominated the market in 2016 and is anticipated to
maintain its dominance by 2025 owing to highly accepted technology in the
market in 2014. This huge share could be ascribed to its advantages over
irrational protein design technology.
The
Protein Engineering Market could be explored based on protein type as Insulin,
Erythropoietin, Vaccines, Monoclonal Antibodies, Interferon, Growth hormones,
Colony Stimulating factor, Coagulation Factor, Others (Follicle Stimulating
Hormones, Enzyme Replacement, and Interleukins). The “Monoclonal Antibodies”
segment dominated the market in 2016 and is anticipated to maintain its
dominance by 2025 owing to increase in acceptance for several treatments such
as autoimmune diseases, and cancer.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/protein-engineering-market
Protein
Engineering industry could be analyzed by end user as contract research
organizations, academic research institutes, and pharmaceutical &
biotechnology companies. The “Pharmaceutical and Biotechnology Companies”
segment dominated the market. The factors contributing to the dominant share
include increase in R&D funds in the pharmaceutical segment, and technological
advancements in protein engineering.
North
America is anticipated to hold the major share of the Protein Engineering
Market. The factors that attribute to the dominant share include growing
occurrence of diseases and rising adoption of protein-based drugs in the
region. The North American market is followed by Europe. On the other hand,
Asia Pacific is estimated to show high growth rates in the upcoming period in
the global market. In the Asia Pacific region, countries such as China and
India are expected to be the fastest-growing markets.
Some
of the key players that fuel the growth of the Protein Engineering industry
comprise Eli Lilly and Company, Thermo Fisher Scientific Inc., Merck KGaA,
Bruker Corporation, PerkinElmer Inc., Agilent Technologies, Waters Corporation,
Novo Nordisk A/S, Bio-Rad Laboratories Inc., Amgen Inc., and among others. The
leading companies are taking up partnerships, mergers and acquisitions, and
joint ventures in order to boost the inorganic growth of the industry.
Market
Segment:
Technology
Outlook (Revenue, USD Million, 2014 - 2025)
• Rational Protein Design
• Directed Evolution
• Hybrid Approach
Product
Outlook (Revenue, USD Million, 2014 - 2025)
• Instruments
• Reagents
• Software & Services
Protein
Type Outlook (Revenue, USD Million, 2014 - 2025)
• Insulin
• Monoclonal Antibodies
• Vaccines
• Growth Factors
• Colony Stimulating Factors
• Coagulation Factors
• Interferon
• Others
Comments
Post a Comment